Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx Group (MDXG) Share-based Compensation: 2011-2025

Historic Share-based Compensation for Mimedx Group (MDXG) over the last 15 years, with Sep 2025 value amounting to $4.9 million.

  • Mimedx Group's Share-based Compensation rose 29.14% to $4.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.6 million, marking a year-over-year increase of 12.03%. This contributed to the annual value of $16.9 million for FY2024, which is 0.15% down from last year.
  • Latest data reveals that Mimedx Group reported Share-based Compensation of $4.9 million as of Q3 2025, which was up 3.51% from $4.8 million recorded in Q2 2025.
  • Mimedx Group's Share-based Compensation's 5-year high stood at $4.9 million during Q3 2025, with a 5-year trough of $530,000 in Q4 2022.
  • Its 3-year average for Share-based Compensation is $4.3 million, with a median of $4.3 million in 2024.
  • In the last 5 years, Mimedx Group's Share-based Compensation slumped by 82.57% in 2022 and then spiked by 727.55% in 2023.
  • Quarterly analysis of 5 years shows Mimedx Group's Share-based Compensation stood at $3.0 million in 2021, then slumped by 82.57% to $530,000 in 2022, then skyrocketed by 727.55% to $4.4 million in 2023, then grew by 7.00% to $4.7 million in 2024, then increased by 29.14% to $4.9 million in 2025.
  • Its Share-based Compensation was $4.9 million in Q3 2025, compared to $4.8 million in Q2 2025 and $4.3 million in Q1 2025.